Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer.
Honglu DingQiuxia YangYize MaoDailei QinZehui YaoRuiqi WangTao QinShengping LiPublished in: Journal of inflammation research (2023)
Owing to the rapid and simple analysis of peripheral blood, baseline SAA might be a useful clinical biomarker, not only as a prognostic biomarker for patients with APC, but also as a guide for the selection of chemotherapy regimens.